After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NYSE-listed company operates within the Drug Manufacturers – Specialty & Generic industry segment, falling under the Healthcare sector. The current market capitalization of Emergent Biosolutions Inc is $624.99M. A total of 0.7 million shares were traded on the day, compared to an average of 1.09M shares.
In the most recent transaction, RONALD RICHARD bought 32,848 shares of EBS for 11.94 per share on Dec 05 ’25. In a previous transaction on Nov 10 ’25, DeGolyer Donald W sold 17,801 shares at 10.54 per share. EBS shares that Director owns now total 119,858.
Among the insiders who sold shares, Dayal Sujata Tyagi disposed of 8,552 shares on Nov 07 ’25 at a per-share price of $10.00. This resulted in the Director holding 88,980 shares of EBS after the transaction. In another insider transaction, DONALD DEGOLYER bought 17,801 shares at $10.54 per share on Nov 10 ’25.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, EBS has a high of $13.41 and a low of $4.02.
As of this writing, EBS has an earnings estimate of $0.11 per share for the current quarter. EPS was calculated based on a consensus of 1.0 estimates, with a high estimate of $0.11 per share and a lower estimate of $0.11. The company reported an EPS of $0.05 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. EBS’s latest balance sheet shows that the firm has $576.10M in Cash & Short Term Investments as of fiscal 2021. There were $841.00M in debt and $374.00M in liabilities at the time. Its Book Value Per Share was $11.05, while its Total Shareholder’s Equity was $1.61B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EBS is Buy with a score of 4.33.
